% | $
Quotes you view appear here for quick access.

NeuroMetrix Inc. Message Board

  • facts2jack facts2jack Nov 15, 2013 12:38 PM Flag

    New to NURO - why was stock trading over $100in 2010?

    I'll do my own DD but wanted a quick heads up from YMB folks in the know on NURO. Your insights are helpful, GLTA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • this is the post they don't want U TO SEE.. lol

    • You do ypor own DD heh? well this company was NOT a 100M company in 2010.. its last time as a 100M company was in 2008.. It has has a series of UNSUSCCEFUL PRODUCTS not just what is left now but Vantage and XCEL before the DPN check and Sensus. Physicians not investors were satisfied with the rollout of these products and neitheThis is the same basic mis-understanding that "kool aid" drinking analysts and investors just never took the time and use of minute due diligence to discover.

      Insurance carriers NEVER "altered" their categoriaztion. They never approved the billing codes used by NURO for NC-Stat in the first place. In fact, they were never asked. NURO just told MD's to submit billing falsely under a set of codes that were only approved for an invasive procedure. When insurance carriers discovered the billing for these codes increased dramatically from MD's that had never submitted them before (vs. neurologists that were qualified to submit), they "shut down" these fraudulent billings.

      The business model of NURO was built on the false hope that insurance carriers would accept the premise of a hand held surface technology being eqal to an invasive needle technology.

      If they had submitted this premise "before" marketing or going public, the answer would have been a resounding NO from insurance carriers.

      The investment community completely dropped the ball and chose to see the naked King clothed in an imaginary robe.
      Nor were the insurance comppanies obligated to pay for them. Then add 5 years time to 2008 and add 2 reverse splits and many private placements to accreditated investors who are never told that the EXECS around here are still getting paid the same level of income they were getting in 2008 even though their 'performance of sales is Not the same. You really figured it out why its a 2 or less stock yet?

1.55-0.01(-0.64%)Sep 29 3:39 PMEDT